home.aspx
 
EVENTS

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...

Breda Genetics srl

No more single gene testing: welcome to Breda Genetics! We always do full exome or full genome sequencing for every patient. Breda Genetics is run by Medical Geneticists and provides patients and laboratories with unparalleled know-how in genetic data interpretation.

RELATED NEWS


Patients on hemodialysis have to undergo vascular access procedures, typically arteriovenous fistulas or arteriovenous grafts. Some, though, are limited to tunneled cuffed catheters due to heart failure or poor cardiac reserve. Properly placing tunneled cuffed catheters can be challenging and failures can lead to serious complications such as clots and central vein thrombosis, in addition to having to repeat the placements. At the Okayama University in Japan, clinical researchers have developed ...
OKAYAMA UNIVERSITY
READ MORE

US regulators have granted AstraZeneca’s Imfinzi breakthrough status for the treatment of certain patients with locally-advanced, unresectable non-small cell lung cancer (NSCLC). The designation relates to patients whose disease has not progressed following platinum-based chemoradiation therapy, highlighting its potential in a much earlier stage in the treatment pathway when the only current option is ‘active monitoring’. Unfortunately, for the majority of patients, their cancer will progress to...

READ MORE

The US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted against Boehringer Ingelheim and Eli Lilly’s diabetes drug, empagliflozin. The panel voted 14 to 2, saying that the benefits of 2.5mg dose of the drug do not outweigh its risks as an adjunct to insulin in adults with type 1 diabetes. Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2). In higher doses, the inhibitors were associated with a life-threatening ...

READ MORE

The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said on Sunday....

READ MORE

New research published in the journal of the Royal Society of Medicine has found that in the UK an estimated 6,000 non-smokers die of lung cancer every year. The statistic makes it a bigger killer than cervical cancer, lymphoma and ovarian cancer. The study also found that smoking still accounts for 86% of lung cancers, but non-smoking lung cancer is the eighth most common cause of cancer-related deaths in the UK and the seventh most prevalent cancer in the world. With declining rates of smoking...

READ MORE

Inspyr Therapeutics, a clinical-stage biotechnology company, and Lewis and Clark Pharmaceuticals today announced the successful completion of a merger to create an integrated biotechnology company. The newly combined company creates a second proprietary technology platform, broad capability laboratory facilities, pipeline of therapeutics, and drug development expertise to create value across the business....

READ MORE

EVENTS

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...